Subscribe to Newsletter

Business & Regulation

Business & Regulation Small Molecules

Bringing Down the House

| Stephanie Vine

Is it a waste when manufacturers demolish facilities before they're even used?

Business & Regulation Contract Development Services

The Contract Career Path

| Ian Muir

Sitting Down With... Ian Muir, Managing Director, Aesica, UK.

Business & Regulation Business Practice

Getting Your Skates On

| Phil Matton

In a price-challenged environment, successful companies embrace change and new strategies.

Business & Regulation Business Practice

The Runaway Outsourcing Train

| Matthew Moorcroft

What can we learn about outsourcing trends from the last 40 years?

Business & Regulation Business Practice

ABPI Sets Out Its Stall

| James Strachan

The ABPI releases a manifesto for the UK’s upcoming election.

Business & Regulation Biosimilars

WHO Wants Cancer Biosimilars

| James Strachan

Will a pilot project to prequalify “generic” biologics improve safe access to medicines?

Business & Regulation Standards & Regulation

European RAPSody

| James Strachan

With big regulatory changes on the horizon, RAPS invests in Europe.

Business & Regulation Business Practice

It’s Just Been Revoked

| James Strachan

PhRMA weeds out 22 members after revising membership rules.

Business & Regulation Business Practice

In Conversation with Lukas Utiger of Patheon at CPhI Worldwide 2016

Charlotte Barker speaks with Lukas Utiger from Patheon.

Business & Regulation Standards & Regulation

Ace Assessor

We Sit Down With Daniel O'Connor, Medical Assessor at the MHRA, UK.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register